Li Jing, Zhang Mei, Yu Chuan-Qing, Xue Min, Hu Pan-Pan
Department of Neurology, The First Hospital of Anhui University of Science and Technology (Huainan First People's Hospital), Huainan, China.
Department of Neurology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Front Aging Neurosci. 2025 May 9;17:1495769. doi: 10.3389/fnagi.2025.1495769. eCollection 2025.
Parkinson's disease (PD) is a common chronic degenerative disease with age-dependent increasing prevalence in the elderly. Non-motor symptoms include sensory deficiencies, autonomic dysfunction, psychological and cognitive abnormalities; while motor symptoms are bradykinesia, myotonia, resting tremor, and postural balance difficulties. The clinical diagnosis of PD depends mainly on patients' medical history and physical examination. It is highly important to realize early detection of PD, and biomarkers are a valuable tool in this regard. The present study reviewed the findings of researches from the last few years, involving the advancements in the study of PD biomarkers in blood, cerebrospinal fluid, saliva, urine, tears, imaging, and pathology.
帕金森病(PD)是一种常见的慢性退行性疾病,在老年人中患病率随年龄增长而增加。非运动症状包括感觉缺陷、自主神经功能障碍、心理和认知异常;而运动症状则为运动迟缓、肌强直、静止性震颤和姿势平衡困难。PD的临床诊断主要依赖于患者的病史和体格检查。实现PD的早期检测非常重要,生物标志物在这方面是一种有价值的工具。本研究回顾了过去几年的研究结果,涉及血液、脑脊液、唾液、尿液、眼泪、影像学和病理学方面PD生物标志物的研究进展。